Dr. Come has acted as a consultant and member of the Speakers' Bureau and has received research support from AstraZeneca. He has also acted as a member of the Speakers' Bureau for Novartis and Pfizer.
Version of Record online: 10 DEC 2007
Copyright © 2007 American Cancer Society
Volume 112, Issue S3, pages 673–678, 1 February 2008
How to Cite
Come, S. E., Buzdar, A. U., Ingle, J. N., Johnston, S. R. D., Brodie, A. M., Coombes, R. C., Miller, W. R., Pritchard, K. I., Winer, E. P., Zujewski, J. A. and Goss, P. E. (2008), Endocrine and targeted manipulation of breast cancer: Summary statement for the Sixth Cambridge Conference. Cancer, 112: 673–678. doi: 10.1002/cncr.23194
The symposium and educational proceedings publications were supported by educational grants provided by AstraZeneca Pharmaceuticals, Pfizer Inc, and Novartis Pharmaceuticals. Program management and Continuing Medical Education Sponsorship were provided by InforMEDical Communications, Inc, Carlisle, Massachusetts
Presented at Endocrine and Targeted Manipulation of Breast Cancer: Proceedings of the Sixth Cambridge Conference, Cambridge, Massachusetts, April 30–May 1, 2007.
- Issue online: 18 JAN 2008
- Version of Record online: 10 DEC 2007
- Manuscript Accepted: 11 OCT 2007
- Manuscript Revised: 8 OCT 2007
- Manuscript Received: 24 AUG 2007